SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RUZZA, Chiara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.111
AS - Asia 3.246
EU - Europa 1.867
SA - Sud America 539
Continente sconosciuto - Info sul continente non disponibili 172
AF - Africa 76
OC - Oceania 5
Totale 12.016
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.970
SG - Singapore 1.231
CN - Cina 718
IT - Italia 568
VN - Vietnam 433
BR - Brasile 404
DE - Germania 238
HK - Hong Kong 231
PL - Polonia 193
GB - Regno Unito 165
BD - Bangladesh 164
FI - Finlandia 142
UA - Ucraina 135
FR - Francia 125
TR - Turchia 103
CA - Canada 84
JP - Giappone 83
RU - Federazione Russa 80
IN - India 76
AR - Argentina 56
ID - Indonesia 53
SE - Svezia 51
MX - Messico 32
NL - Olanda 31
ZA - Sudafrica 29
IQ - Iraq 25
PK - Pakistan 25
ES - Italia 22
EC - Ecuador 20
BE - Belgio 19
IE - Irlanda 19
AT - Austria 15
CZ - Repubblica Ceca 15
UZ - Uzbekistan 15
VE - Venezuela 15
LT - Lituania 14
CO - Colombia 13
AE - Emirati Arabi Uniti 11
KE - Kenya 10
MY - Malesia 10
TN - Tunisia 10
PH - Filippine 9
SA - Arabia Saudita 9
JM - Giamaica 7
PE - Perù 7
PY - Paraguay 7
UY - Uruguay 7
CH - Svizzera 6
KR - Corea 6
NP - Nepal 6
AZ - Azerbaigian 5
CL - Cile 5
DZ - Algeria 5
KZ - Kazakistan 5
MA - Marocco 5
AL - Albania 4
AU - Australia 4
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
EG - Egitto 4
IL - Israele 4
JO - Giordania 4
RO - Romania 4
BO - Bolivia 3
IR - Iran 3
KW - Kuwait 3
NG - Nigeria 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BB - Barbados 2
CR - Costa Rica 2
GY - Guiana 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
TH - Thailandia 2
ZW - Zimbabwe 2
BJ - Benin 1
CI - Costa d'Avorio 1
DM - Dominica 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NZ - Nuova Zelanda 1
Totale 11.839
Salva come PNG Salva come JPEG
Città #
Ashburn 950
Singapore 760
Fairfield 498
San Jose 475
Woodbridge 401
Santa Clara 276
Beijing 255
Houston 242
Seattle 221
Hong Kong 219
Cambridge 194
Warsaw 186
Ann Arbor 183
Wilmington 183
Ferrara 162
Los Angeles 162
Chandler 161
New York 155
Jacksonville 154
Ho Chi Minh City 148
Council Bluffs 97
Hanoi 92
Dallas 91
Munich 87
Tokyo 76
Helsinki 71
Shanghai 68
Milan 67
Lauterbourg 65
Princeton 58
Izmir 53
Bologna 47
Nanjing 44
Chicago 43
São Paulo 40
Jakarta 38
London 38
Orem 38
San Diego 34
Toronto 32
Dearborn 31
Atlanta 30
Da Nang 28
Turku 28
Boardman 27
Frankfurt am Main 25
Brooklyn 24
Buffalo 23
Denver 21
Montreal 21
Phoenix 20
Chennai 19
Mexico City 19
Brussels 18
Dublin 18
Belo Horizonte 16
Falkenstein 16
Johannesburg 16
Lappeenranta 16
Rio de Janeiro 16
Addison 15
Moscow 14
Nanchang 14
San Francisco 14
Stockholm 14
Tashkent 14
Guangzhou 13
Hefei 13
Manchester 13
Memphis 13
Shenyang 13
Tianjin 13
Washington 13
Assago 12
Brasília 12
Falls Church 12
Norwalk 12
Piscataway 12
Rome 12
The Dalles 12
Haiphong 11
Mumbai 11
Naples 11
Padova 11
Biên Hòa 10
Lahore 10
Nairobi 10
Vienna 10
Bremen 9
Charlotte 9
Dhaka 9
Poplar 9
Baghdad 8
Boston 8
Changsha 8
Hải Dương 8
Newark 8
Nuremberg 8
Porto Alegre 8
Redwood City 8
Totale 8.040
Salva come PNG Salva come JPEG
Nome #
Pharmacological and neurobiological studies on Neuropeptide S and its receptor 277
Preclinical effects of cannabidiol in an experimental model of migraine 267
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 263
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 256
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 252
Biased Agonism at Nociceptin/Orphanin FQ Receptors: A Structure Activity Study on N/OFQ(1-13)-NH2 244
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 241
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 237
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 234
Modulation of the NOP receptor signaling affects resilience to acute stress 230
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 230
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 227
Neuropeptide S receptor ligands: a patent review (2005-2016) 221
Pharmacological characterization of tachykinin tetrabranched derivatives 219
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 215
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 212
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands 208
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 208
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 206
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 203
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 201
Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies 198
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Structure-activity study at positions 3 and 4 of human neuropeptide S. 196
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 196
Tetrabranched Hetero-Conjugated Peptides as Bifunctional Agonists of the NOP and Mu Opioid Receptors 194
Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68). 192
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 181
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 181
NOP agonist action of cebranopadol counteracts its liability to promote physical dependence 176
Novel Mixed NOP/Opioid Receptor Peptide Agonists 172
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 165
Structure-Activity Relationship Studies on Oxazolo[3,4- a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent in Vivo Activity 162
Lack of Direct Effects of Neurotrophic Factors in an In Vitro Model of Neuroinflammation 159
NOP agonists prevent the antidepressant-like effects of nortriptyline and fluoxetine but not R-ketamine 154
Functional Selectivity Does Not Predict Antinociceptive/Locomotor Impairing Potencies of NOP Receptor Agonists 153
Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test 145
The concise guide to pharmacology 2021/22: G protein-coupled receptors 145
Synthesis and Pharmacological Evaluation of Hybrids Targeting Opioid and Neurokinin Receptors 144
Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders 143
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 142
Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis 136
Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice 133
Detailed in vitro pharmacological characterization of the clinically viable nociceptin/orphanin FQ peptide receptor antagonist BTRX-246040 133
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics 130
Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice 126
NOP Ligands for the Treatment of Anxiety and Mood Disorders 125
The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus 121
In vitro pharmacological characterization of growth hormone secretagogue receptor ligands using the dynamic mass redistribution and calcium mobilization assays 120
Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors 120
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress 120
Activation of NOP receptor increases vulnerability to stress: role of glucocorticoids and CRF signaling 119
In vitro pharmacological evaluation of the novel NOP receptor partial agonist sunobinop 116
Sex differences in response to NLRP3 inflammasome blockage in a mouse migraine model: A genetic and pharmacological study 115
Pharmacological characterization of naloxegol: In vitro and in vivo studies 115
The concise guide to pharmacology 2019/20: G protein-coupled receptors 114
Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo 114
Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68. 112
Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test 111
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 110
null 110
Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice 107
null 105
Racemic synthesis and solid phase peptide synthesis application of the chimeric valine/leucine derivative 2-amino-3,3,4-trimethyl-pentanoic acid 102
Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ-NOP Receptor System 102
In vitro pharmacological characterization of standard and new lysophosphatidic acid receptor antagonists using dynamic mass redistribution assay 94
null 87
Synthesis and Pharmacological Characterization of Nociceptin/Orphanin FQ Dimeric Ligands 86
Pharmacology, physiology and genetics of the neuropeptide s system 85
Nociceptin/OrphaninFQ Receptor Modulates the Maturation of Adult-Born Neurons in the Mouse Dentate Gyrus Under Physiological Conditions and in a Chronic Stress Model 79
null 77
Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress 69
The concise guide to pharmacology 2017/18: Overview 62
An Insight into Neuronal Processing of Ghrelin: Effects of a Bioactive Ghrelin Derivative on Proteolytic Pathways and Mitophagy 59
null 42
Totale 12.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 55.537
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 810
Totale 56.347
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 33 35 28 39 37 38 27 41 24 52 35 135
2022/2023455 58 42 23 48 58 44 39 37 50 5 27 24
2023/2024427 32 47 25 14 26 78 22 39 4 21 14 105
2024/20251.682 43 43 153 73 191 177 16 73 293 169 238 213
2025/20265.597 562 274 407 619 806 348 663 331 504 548 348 187
2026/2027377 377 0 0 0 0 0 0 0 0 0 0 0
Totale 12.016